TransCode Therapeutics, Inc. Announces Closing of Registered Direct Offering Mar 25, 2025 06:24PM
TransCode Therapeutics, Inc. Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Mar 23, 2025 11:11PM
TransCode Therapeutics, Inc. Announces Closing of Public Offering Jul 24, 2024 04:05PM
TransCode Therapeutics, Inc. Announces Pricing of Public Offering Jul 22, 2024 10:30PM
TransCode Therapeutics (RNAZ) Announces Proposed Share Offering Jul 22, 2024 04:07PM


Jul 22, 2024 04:07PM TransCode Therapeutics, Inc. Announces Proposed Public Offering of Common Stock
Oct 26, 2023 04:20PM TransCode Therapeutics (RNAZ) Announces Proposed Share Offering
Oct 26, 2023 04:19PM TransCode Therapeutics Announces Public Offering of Common Stock
Sep 28, 2023 04:02PM TransCode Therapeutics Announces Closing of $8.5 Million Public Offering
Sep 26, 2023 05:04AM TransCode Therapeutics (RNAZ) Prices 15.7M Share Offering at $0.51/sh
Sep 25, 2023 08:01PM TransCode Therapeutics Announces Pricing of $8 Million Public Offering
Oct 19, 2022 08:00AM TransCode Therapeutics: Invitation to The ThinkEquity Conference
Jul 13, 2021 04:30PM TransCode Therapeutics, Inc. Announces Closing of Initial Public Offering, Including Full Exercise of Underwriters' Over-allotment Option
Jul 9, 2021 05:25AM TransCode Therapeutics, Inc (RNAZ) Prices 6.25M Share IPO at $4/sh
Jul 8, 2021 06:34PM TransCode Therapeutics, Inc. Announces Pricing of Initial Public Offering